
IndraLab
Statements
Hydroxychloroquine inhibits TNF. 48 / 48
|
10
38
reach
"HCQ and CQ inhibit major histocompatability complex (MHC) class II expression; production of IL-1, IFNalpha and TNF and interfere with cyclic GMP-AMP synthase activity partly by accumulating in lysosomes and autophagosomes of phagocytic cells and changing local pH concentrations [XREF_BIBR]."
reach
"These antiviral effects Proposed mechanisms for chloroquine and hydroxychloroquine Inhibition of nanoparticle uptake TNF alpha IFN gamma combined with immunomodulatory properties are promising, and thus over the last 3 months, multiple studies have been launched to leverage these benefits in the clinical setting.A majority of the putative antiviral effects of chloroquine/HCQ molecules on the SARS-CoV-2 are the result of the indirect inferences drawn from the data available on SARS-CoV-1 or from an alternate viral model, that is, Epstein-Barr virus (EBV), HIV, and so forth."
reach
"This dichotomous effect (inhibition of CD4 T-cell stimulation and promotion of CD8 T-cell stimulation), which still needs to be demonstrated with chronic antimalarial use, may explain in part the paucity of opportunistic infections during antimalarial therapy.In vitro studies have shown that both chloroquine and hydroxychloroquine decrease the production of TNF-α , IL-6, and IFN-γ by mitogen-stimulated peripheral blood lymphocytes (38)."
reach
"A recent study reported a reduced detection of SARS-CoV-2 RNA in upper respiratory tract specimens from patients treated with hydroxychloroquine.3 Hydroxychloroquine may also suppress proinflammatory cytokines (Tumor Necrosis Factor [TNF]-alpha and IL-6) associated with coronavirus-induced ARDS.4 Based on this information and limited anecdotal data, we treated our patient with hydroxychloroquine."
reach
"This dichotomous effect (inhibition of CD4 T‐cell stimulation and promotion of CD8 T‐cell stimulation), which still needs to be demonstrated with chronic antimalarial use, may explain in part the paucity of opportunistic infections during antimalarial therapy.In vitro studies have shown that both chloroquine and hydroxychloroquine decrease the production of TNF‐α, IL‐6, and IFN‐γ by mitogen‐stimulated peripheral blood lymphocytes (38)."